台股 » 個股 » 共信-KY » 籌碼相關 » 券商分點績效 » 券商分點個股進出

共信-KY

(6617)
  • 股價
    126.0
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    283
  • 產業
    上櫃 生技醫療類股
  • 42人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
共信-KY (6617)籌碼相關-元大-蘆洲 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-蘆洲 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/09/051126.5000.00126.0015590.18%
2024/09/040131.001132.00133.50-1556-0.18%
2024/09/031131.9800.00129.5015470.18%
2024/08/280127.502131.50133.50-2565-0.35%
2024/08/270126.0000.00127.5005570.00%
2024/08/261125.5000.00125.5015550.18%
2024/08/237129.572127.25126.0055520.90%
2024/08/221127.001130.00129.0005430.00%
2024/08/212119.002121.50121.5005280.00%
2024/08/200104.0000.00113.0005120.00%
2024/08/15099.9000.0098.5005020.00%
2024/08/140102.501100.0096.50-1499-0.19%
2024/08/130103.001.2101.92101.00-1.2491-0.24%
2024/08/091101.002103.50102.00-1490-0.20%
2024/08/0800.0012102.25102.50-12487-2.46%
2024/08/070112.0000.00108.5004840.01%
2024/08/061109.512101.00103.50-1471-0.21%
2024/08/051112.5000.00112.0014640.22%
2024/07/310131.5000.00130.5004560.01%
2024/07/300131.0000.00132.5004540.01%
2024/07/2600.001137.50136.00-1448-0.22%
2024/07/230140.000.1139.00140.50-0.1445-0.02%
2024/07/226142.332139.50138.5044420.90%
2024/07/192142.7500.00142.0024370.46%
2024/07/170135.5000.00136.0004180.01%
2024/07/1600.003.1135.43136.00-3.1416-0.74%
2024/07/120.1136.0000.00135.000.14100.02%
2024/07/1100.000137.00135.0004090.00%
2024/07/100.1136.181135.50135.00-0.9408-0.22%
2024/07/090.1136.0000.00136.000.14080.02%
2024/07/081.2137.832136.00135.00-0.8409-0.20%
2024/07/0500.007138.50139.50-7404-1.73%
2024/07/041144.5000.00140.0014020.25%
2024/07/031.1136.231138.00143.000.13930.03%
2024/07/020140.0000.00137.5003830.00%
2024/06/272150.0000.00147.0023690.54%
2024/06/248151.7500.00147.0083292.43%
2024/06/2112154.921159.00160.00113003.66%
2024/06/200.1138.003142.00146.50-2.9253-1.14%
2024/06/192133.4900.00128.5022140.94%
2024/06/183.3130.181132.50132.002.31991.15%
〈熱門股〉共信-KY旗下PTS進軍寵物市場 跌深反彈周漲逾2成Anue鉅亨-14天前
共信-KY動物抗癌新藥申請台灣藥證 明年H2有望取得藥證Anue鉅亨-2024/07/31
共信-KY 相關文章
共信-KY 相關影音